Bausch Health Companies (TSE:BHC) Sets New 1-Year Low – Should You Sell?

Bausch Health Companies Inc. (TSE:BHC)’s share price reached a new 52-week low on Wednesday . The stock traded as low as C$6.71 and last traded at C$6.72, with a volume of 496491 shares trading hands. The stock had previously closed at C$6.93.

Bausch Health Companies Trading Down 3.0%

The company has a debt-to-equity ratio of -1,009.96, a quick ratio of 0.58 and a current ratio of 1.32. The company has a 50 day simple moving average of C$7.51 and a two-hundred day simple moving average of C$8.22. The firm has a market cap of C$2.51 billion, a PE ratio of -2.07, a P/E/G ratio of 0.21 and a beta of 0.94.

Bausch Health Companies (TSE:BHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported C$1.08 earnings per share for the quarter. The business had revenue of C$3.51 billion for the quarter. Bausch Health Companies had a positive return on equity of 120.43% and a negative net margin of 13.54%. Analysts expect that Bausch Health Companies Inc. will post 5.5472637 EPS for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.